Metabolic FingerPrinting
- Conditions
- Genetic Disease
- Interventions
- Other: No intervention
- Registration Number
- NCT05305729
- Lead Sponsor
- Arcensus GmbH
- Brief Summary
The MetaPrint study aims to characterize the metabolic fingerprint of genetic diseases in order to enhance knowledge on the physiological disease status and establish so new tools for diagnosing, monitoring and personalizing treatment of genetic diseases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 10000
- Informed consent is obtained from the participant or from the parent/ legal guardian
- The participant is 2 months or older
- The participant is diagnosed with a genetic disease
- The participant is a first degree relative of a subject diagnosed with a genetic disease
- Informed consent is not obtained from the participant or from the parent/ legal guardian
- The participant is younger than 2 months
- The participant is not diagnosed with a genetic disease
- The participant is not a first degree relative of a subject diagnosed with a genetic disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Subjects with a genetic disease No intervention -
- Primary Outcome Measures
Name Time Method Number of newly identified, disease-specific Metabolic Fingerprints 5 years Plasma-derived metabolite profiles that are specific for a particular genetic disease in comparison to healthy controls and other genetic diseases
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
University Hospital Center Mother Teresa
🇦🇱Tirana, Albania
Khyber institute of Child Health and Children Hospital (KICH)
🇵🇰Peshawar, Pakistan
The Children's hospital & Institute of child health
🇵🇰Lahore, Punjab, Pakistan
Children's Hospital & The Institute of Child Health
🇵🇰Multan, Pakistan
Pakistan Institute of Medical Sciences (PIMS)
🇵🇰Islamabad, Pakistan